Long-term Renal Prognosis of Diarrhea-Associated Hemolytic Uremic Syndrome: A Systematic Review, Meta-analysis, and Meta-regression

JAMA

Volumn 290, Issue 10, 2003, Pages 1360-1370

  Garg, Amit X ^a,b,d   Suri, Rita S ^b   Barrowman, Nick ^c   Rehman, Faisal ^b   Matsell, Doug ^b   Rosas Arellano, M Patricia ^b   Salvadori, Marina ^b   Haynes, R Brian ^b,d   Clark, William F ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Thomas C Chalmers Ctr Syst Rev   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COMA; CONFIDENCE INTERVAL; CREATININE CLEARANCE; DATA BASE; DEATH; DIARRHEA; DISEASE SEVERITY; EMBASE; ESCHERICHIA COLI; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPONATREMIA; KIDNEY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LITERATURE; LONG TERM CARE; LONGITUDINAL STUDY; MEDLINE; META ANALYSIS; METHODOLOGY; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; PURPURA; QUALITY CONTROL; REVIEW; SEIZURE; STATISTICAL ANALYSIS; STROKE; SYMPTOMATOLOGY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; CHRONIC KIDNEY FAILURE; ENTEROBACTER INFECTION; MORTALITY; REGRESSION ANALYSIS; SURVIVAL;

DIARRHEA; ESCHERICHIA COLI INFECTIONS; GLOMERULAR FILTRATION RATE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; PROGNOSIS; PROTEINURIA; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 0041411081     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.10.1360     Document Type: Review

References (74)

1. Tarr PI, Neill MA, Allen J, Siccardi CJ, Watkins SL, Hickman RO. The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: lack of evidence for ascertainment bias. Am J Epidemiol. 1989;129:582-586.
2. Martin DL, MacDonald KL, White KE, Soler JT, Osterholm MT. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med. 1990;323:1161-1167.
3. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985;151:775-782.
4. Ray PE, Liu XH. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol. 2001;16:823-839.
5. Small G, Watson AR, Evans JH, Gallagher J. Hemolytic uremic syndrome: defining the need for long-term follow-up. Clin Nephrol. 1999;52:352-356.
6. O'Brien JA, Van Why SK, Keller MS, Gaudio KM, Kennedy TL, Siegel NJ. Altered renovascular resistance after spontaneous recovery from hemolytic uremic syndrome. Yale J Biol Med. 1994;67:1-14.
7. O'Regan S, Blais N, Russo P, Pison CF, Rousseau E. Hemolytic uremic syndrome: glomerular filtration rate, 6 to 11 years later measured by 99mTc DTPA plasma slope clearance. Clin Nephrol. 1989;32:217-220.
8. Brandt JR, Joseph MW, Fouser LS, et al. Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol. 1998;12:222-225.
9. Huseman D, Gellermann J, Vollmer I, et al. Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol. 1999;13:672-677.
10. Wende-Fischer R, Hoyer PF, Offner G, Brodehl J. Hamolytisch-uramisches Syndrom im Kindesalter: Haemolytic uraemic syndrome. Monatsschr Kinderheilkd. 1996;144:526-533.
11. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc. 1994;1:447-458.
12. Ogborn MR, Hamiwka L, Orrbine E, et al. Renal function in Inuit survivors of epidemic hemolyticuremic syndrome. Pediatr Nephrol. 1998;12:485-488.
13. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857-872.
14. Zhou XH, Brizendine EJ, Pritz MB. Methods for combining rates from several studies. Stat Med. 1999;18:557-566.
15. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049-1060.
16. Schieppati A, Ruggenenti P, Cornejo RP et al. Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome: the Italian Registry of Haemolytic Uremic Syndrome. J Am Soc Nephrol. 1992;2:1640-1644.
17. Campos A, Kim Y, Miller K, Mauer SM, Loken MK, Michael AF. Radionuclide studies of the kidney in children with hemolytic-uremic syndrome. Radiology. 1982;145:811-813.
18. Monnens L, van Collenburg J, de Jong M, Zoethout H, Van Wieringen P. Treatment of the hemolytic-uremic syndrome: comparison of the results of heparin treatment with the results of streptokinase treatment. Helv Paediatr Acta. 1978;33:321-328.
19. Janssen F, Potvliege PR, Vainsel M, Vis HL. Short- and long-term prognosis of the hemolytic-uremic syndrome. Arch Fr Pediatr. 1974;31:59-69.
20. de Jong M, Monnens L. Haemolytic-uraemic syndrome: a 10-year follow-up study of 73 patients. Nephrol Dial Transplant. 1988;3:379-382.
21. Gillor A, Roth B, Bulla M, Gunther H, Gladtke E. Plasmapherese bei der Behandlung von Kindern mit hamolytisch-uramischem Syndrom. Nieren-und Hochdruckkrankheiten. 1986;15:118-123.
22. Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo G. The hemolytic-uremic syndrome: renal status of 76 patients at long-term follow-up. J Pediatr. 1968;72:757-765.
23. Tonshoff B, Sammet A, Sanden I, Mehls O, Waldherr R, Scharer K. Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron. 1994;68:63-70.
24. Litalien C, Proulx F, Mariscalco MM, et al. Circulating inflammatory cytokine levels in hemolytic uremic syndrome. Pediatr Nephrol. 1999;13:840-845.
25. Gagnadoux MF, Habib R, Gubler MC, Bacri JL, Broyer M. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome. Clin Nephrol. 1996;46:39-41.
26. Dolislager D, Tune B. The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome. Am J Dis Child. 1978;132:55-58.
27. Donckerwolcke RA, Kuijten RH, Tiddens HA, van GJ. Haemolytic uraemic syndrome. Paediatrician. 1979;8:378-393.
28. McLean MM, Jones CH, Sutherland DA. Haemolytic-uraemic syndrome: a report of an outbreak. Arch Dis Child. 1966;41:76-81.
29. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Long term renal outcome of childhood haemolytic uraemic syndrome. BMJ. 1991;303:489-492.
30. Riella MC, George CR, Hickman RO, et al. Renal microangiopathy of the hemolytic-uremic syndrome in childhood. Nephron. 1976;17:188-203.
31. Blahova K, Janda J, Kreisinger J, Matejkova E, Sediva A. Long-term follow-up of Czech children with D+ hemolytic uremic syndrome. Pediatr Nephrol. 2002;17:400-403.
32. Sorrenti LY, Lewy PR. The hemolytic-uremic syndrome: experience at a center in the Midwest. Am J Dis Child. 1978;132:59-62.
33. Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol. 1997;11:156-160.
34. Cordero J, Baeza J, Fielbaum O, et al. Hemolyticuremic syndrome: experience with 154 cases. Rev Chil Pediatr. 1990;61:235-242.
35. Donckerwolcke RA, Tiddens HA, Kuijten RH. A prospective study of the haemolytic-uremic syndrome [author's translation]. Acta Paediatr Belg. 1973;27:284-298.
36. Kelles A, Van Dyck M, Proesmans W. Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features. Eur J Pediatr. 1994;153:38-42.
37. Gusmano R, Perfumo F, Ciardi MR, Sarperi M. Long-term prognosis of haemolytic-uraemic syndrome in children. Adv Exp Med Biol. 1987;212:199-204.
38. Coad NA, Marshall T, Rowe B, Taylor CM. Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Clin Nephrol. 1991;35:10-16.
39. Siegler RL, Pavia AT, Hansen FL, Christofferson RD, Cook JB. Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. J Pediatr. 1996;128:505-511.
40. Sheth KJ, Gill JC, Hanna J, Leichter HE. Failure of fresh frozen plasma infusions to alter the course of hemolytic uremic syndrome. Child Nephrol Urol. 1988;9:38-41.
41. Hughes DA, Beattie TJ, Murphy AV. Haemolytic uraemic syndrome: 17 years' experience in a Scottish paediatric renal unit. Scott Med J. 1991;36:9-12.
42. Zurowska A, Gockowska Z, Czarniak P, Marczak E. Changing clinical course of hemolytic uremic syndrome in children, Pol Merkuriusz Lek. 2000;8:234-235.
43. Diekmann L. Treatment of the hemolytic-uremic syndrome with streptokinase and heparin [author's translation]. Klin Padiatr. 1980;192:430-435.
44. Imoberdorf G, Bianchetti MG, Rossi E, Gugler E, Oetliker OH. Hemolytic-uremic syndrome in children: a 19-year retrospective study. Schweiz Med Wochenschr. 1993;123:1439-1444.
45. Vermylen C, Bodart E, Ninane J, Moulin D, Cornu G. The haemolytic uraemic syndrome of childhood: is living in Belgium a factor of good prognosis? Acta Clin Belg. 1988;43:101-108.
46. Loirat C, Baudouin V, Sonsino E, Mariani-Kurdjian P, Elion J. Hemolytic-uremic syndrome in the child. Adv Nephrol Necker Hosp. 1993;22:141-168.
47. Loirat C, Beaufils F, Sonsino E, et al. Treatment of childhood hemolytic-uremic syndrome with urokinase: cooperative controlled trial. Arch Fr Pediatr. 1984;41:15-19.
48. Mizusawa Y, Pitcher LA, Burke JR, Falk MC, Mizushima W. Survey of haemolytic-uraemic syndrome in Queensland 1979-1995. Med J Aust. 1996;165:188-191.
49. Guyot C, Daniel MD, Roze JC, Renoult E, Dubigeon P, Buzelin F. Prognosis of hemolytic uremic syndrome in children: importance of extrarenal involvement. Arch Fr Pediatr. 1986;43:253-258.
50. Rizzoni G, Claris-Appiani A, Edefonti A, et al. Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr. 1988;112:284-290.
51. Loirat C, Sonsino E, Hinglais N, Jais JP, Landais P, Fermanian J. Treatment of the childhood haemolytic uraemic syndrome with plasma: a multicentre randomized controlled trial. Pediatr Nephrol. 1988;2:279-285.
52. Al-Eisa A, Al-Hajeri M. Hemolytic uremic syndrome in Kuwaiti Arab children. Pediatr Nephrol. 2001;16:1093-1098.
53. Miyazaki S. The etiology and clinical features of hemolytic uremic syndrome. Rinsho Ketsueki. 1994;35:341-345.
54. Brichard B, Vermylen C, Heremans MT, Ninane J, Cornu G. Plasma infusion as treatment for 33 children with haemolytic uraemic syndrome: a good therapy? Acta Clin Belg. 1993;48:156-163.
55. Ramos S, Gomes L, Sarmento A, et al. Sindrome Hemolitico-Uremico Casuistica de uma decada. Nascer e Crescer. 2001;10:82-87.
56. Henning PH, Tham EB, Martin AA, Beare TH, Jureidini KF. Haemolytic-uraemic syndrome outbreak caused by Escherichia coli O111:H-: clinical outcomes. Med J Aust. 1998;168:552-555.
57. Yoshioka K, Yagi K, Moriguchi N. Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: experience of an outbreak in Sakai City, 1996. Pediatr Int. 1999;41:223-227.
58. Salvadori M, Garg A, Howard J, Clark W, Matsell D. An outbreak of E. coli O157:H7 infections due to a contaminated municipal water supply in rural Ontaro. Short-term outcome of children developing hemolytic uremic syndrome. [abstract]. J Am Soc Nephrol 2002;13(suppl S):699.
59. Orr P, Dong V, Lorencz B, et al. Hemolytic uremic syndrome secondary to an outbreak of verotoxin producing E. coli in the Canadian Arctic. Artic Med Res. 1994;53(suppl 2):630-634.
60. Schwartz GJ, Haycock GB, Edelmann CMJ, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259-263.
61. Bale JF Jr, Brasher C, Siegler RL. CNS manifestations of the hemolytic-uremic syndrome: relationship to metabolic alterations and prognosis. Am J Dis Child. 1980;134:869-872.
62. Moghal NE, Ferreira MA, Howie AJ, Milford DV, Raafat E, Taylor CM. The late histologic findings in diarrhea-associated hemolytic uremic syndrome. J Pediatr. 1998;133:220-223.
63. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996;49:1774-1777.
64. Wingen AM, Fabian-Bach C, Schaefer F, Mehls O, for the European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. Lancet. 1997;349:1117-1123.
65. Tufro A, Arrizurieta EE, Repetto H. Renal functional reserve in children with a previous episode of haemolytic-uraemic syndrome. Pediatr Nephrol. 1991;5:184-188.
66. Perelstein EM, Grunfield BG, Simsolo RB, Gimenez MI, Gianantonio CA. Renal functional reserve compared in haemolytic uraemic syndrome and single kidney. Arch Dis Child. 1990;65:728-731.
67. Todd WT. Prospects for the prevention of haemolytic-uraemic syndrome. Lancet. 2001;357:1636-1638.
68. Bell BP, Goldoft M, Griffin PM, et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: the Washington experience. JAMA. 1994;272:1349-1353.
69. Kawamura N, Yamazaki T, Tamai H. Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome. Pediatr Int. 1999;41:218-222.
70. Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA. 2002;288:996-1001.
71. Matise I, Cornick NA, Booher SL, Samuel JE, Bosworth BT, Moon HW. Intervention with Shiga toxin (Stx) antibody after infection by Stx-producing Escherichia coli. J Infect Dis. 2001;183:347-350.
72. Armstrong GD, Rowe PC, Goodyer P, et al. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J Infect Dis. 1995;171:1042-1045.
73. Perez N, Spizzirri F, Rahman R, Suarez A, Larrubia C, Lasarte P. Steroids in the hemolytic uremic syndrome. Pediatr Nephrol. 1998;12;101-104.
74. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21:1559-1573.